US Digital Health Company Profusa Plans to Acquire Multi-Omics Precision Diagnostics Platform for $30 Million
Profusa, a Nasdaq-listed company headquartered in Berkeley, California, announced that it has signed...
U.S. FDA Approves Allevion Medical's Minimally Invasive Surgical System
The U.S. Food and Drug Administration (FDA) recently approved Allevion Medical's Vantage system, whi...
Rising Incidence of Radiation Therapy-Related Acute Myeloid Leukemia
New population-based study data from the Osaka International Cancer Institute in Japan shows that al...
IDEAYA Biosciences Initiates Clinical Trial for New Drug to Address Solid Tumors and Cancer Drug Resistance
IDEAYA Biosciences, Inc., a precision medicine oncology company in the United States, announced that...
World's First! China's Radiomedicine's Nuclear Drug 99mTc-3PRGD2 Broad-Spectrum Tumor Imaging Agent Approved for Market Launch
On April 2, 2026, the China National Medical Products Administration approved the market launch of T...
U.S. Azurity Pharmaceuticals Launches New Oral Solution for Treating Attention Deficit Hyperactivity Disorder
Azurity Pharmaceuticals, Inc., a company dedicated to providing innovative pharmaceutical solutions ...
Christ Hospital Launches AI Virtual Assistant for Heart Failure Patient Care
On April 2, 2026, a pilot randomized controlled trial showed that an AI virtual assistant designed f...
GEA and Hovione Collaborate to Launch Solution Accelerating Smart Tablet Manufacturing Development
German company GEA and Portuguese firm Hovione have joined forces to launch the SimpleCT solution, a...
$400 Million to Buy a "Pharmaceutical Brain": Anthropic Makes Its First Acquisition of AI Biotech Company Coefficient Bio
Claude's parent company has started buying "pharmaceutical brains." Anthropic has acquired AI biotec...
American Anshar AI Launches Healthcare Agent Tools, Reducing Claim Processing Time from Ten Hours to Minutes
Pinaki Saha, founder and CEO of Anshar AI, stated that approximately 40% to 50% of medical claims in...